According to the BioNTech said in a statement that it had started work on a vaccine tailored to new coronavirus variant Omicron which was firstly detected in South Africa, though it was not yet clear if it would have to rework its established coronavirus shot.
As per details, The BioNTech said in its statement that the development of an adapted vaccine is part of the company’s standard procedure for new variants, BioNTech, which makes vaccines together with Pfizer.
The statement further reads that “The first steps of developing a potential new vaccine overlap with the research necessary in order to evaluate whether a new shot will be needed,”
The new variant of COVID-19 Omicron carries a very high global risk of surges, the World Health Organization (WHO) warned as more countries reported cases, prompting border closures.
The BioNTech had said it expects more lab data over the next 2 weeks to help determine if there is need for an Omicron-specific vaccine.
On the other hand BioNTech’s rival Moderna has said it was working on a redesign of its coronavirus vaccine for future booster shots.
Your email address will not be published. Required fields are marked *